GlassScriptPhysician profile
Rajan Khosla
NPI 1770583601
$18,350.88
in general payments reported to CMS, 2019-2025
50 companies · $3,305 in 2025
The $3,305 reported for 2025 was more than what 88% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,253 · 2020: $615 · 2021: $1,557 · 2022: $2,715 · 2023: $5,083 · 2024: $3,824 · 2025: $3,305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $53.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,158.37 |
| Education | $53.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,560.38 | 2019-2025 | |
| Janssen Biotech, INC. | $2,071.31 | 2019-2025 | Stelara, Tremfya, Simponi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,472.06 | 2019-2025 | Xifaxan, Trulance, Plenvu |
| Takeda Pharmaceuticals U.S.A., INC. | $1,276.74 | 2019-2025 | Entyvio, Eohilia, Vpriv |
| Pfizer INC. | $993.26 | 2019-2025 | |
| Celgene Corporation | $986.67 | 2021-2024 | Zeposia |
| Qol Medical, LLC | $693.34 | 2019-2025 | Sucraid, Sucraid |
| Regeneron Healthcare Solutions, INC. | $563.16 | 2022-2025 | Dupixent |
| Ferring Pharmaceuticals INC. | $541.14 | 2021-2025 | Rebyota, Cimzia, Clenpiq |
| Ardelyx, INC. | $489.81 | 2023-2025 | Ibsrela |
| Gilead Sciences, INC. | $409.27 | 2019-2025 | Livdelzi |
| Genzyme Corporation | $378.36 | 2022-2025 | |
| Lilly USA, LLC | $282.49 | 2024-2025 | Omvoh |
| Phathom Pharmaceuticals, INC. | $267.87 | 2023-2025 | Voquezna |
| Nestle Healthcare Nutrition INC. | $265.35 | 2021-2023 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $264.00 | 2021-2024 | Talicia, Movantik, Aemcolo |
| Daiichi Sankyo INC. | $255.24 | 2020-2025 | Injectafer |
| Ironwood Pharmaceuticals, INC | $248.43 | 2021-2024 | Linzess |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $247.05 | 2023 | |
| Ipsen Biopharmaceuticals, INC | $237.83 | 2024-2025 | Iqirvo |
| Echosens North America, INC. | $204.47 | 2021-2023 | Fibroscan |
| Intercept Pharmaceuticals, INC. | $191.70 | 2020-2025 | Ocaliva |
| E.R. Squibb & Sons, L.L.C. | $134.39 | 2024 | Zeposia |
| Medtronic, INC. | $134.22 | 2021-2024 | Pillcam, Interstim, Gi Genius |
| Allergan, INC. | $122.28 | 2019-2020 | |
| Aimmune Therapeutics, INC. | $100.85 | 2025 | Zenpep, Vowst |
| Boston Scientific Corporation | $90.04 | 2022 | |
| Lucid Diagnostics INC. | $78.08 | 2021-2023 | |
| Madrigal Pharmaceuticals | $76.64 | 2025 | Rezdiffra |
| Ucb, INC. | $74.60 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $68.06 | 2023-2024 | Cyltezo |
| Endo Pharmaceuticals INC. | $52.65 | 2019-2020 | |
| Abbott Laboratories | $48.04 | 2021 | |
| Orphalan INC | $47.28 | 2025 | Cuvrior |
| Novo Nordisk INC | $44.93 | 2025 | Wegovy |
| Celltrion USA INC. | $40.62 | 2023-2024 | Zymfentra, Yuflyma |
| Merck Sharp & Dohme LLC | $37.46 | 2019-2020 | |
| Braintree Laboratories, INC. | $37.41 | 2023-2025 | Sutab, Suflave |
| Olympus America INC. | $35.61 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $33.49 | 2019 | |
| Evoke Pharma, INC. | $30.32 | 2024-2025 | |
| W. L. Gore & Associates, INC. | $28.05 | 2022-2023 | Gore Cardioform Septal Occluder |
| Fresenius Kabi USA, LLC | $26.00 | 2023 | Idacio |
| Intuitive Surgical, INC. | $23.33 | 2023 | |
| Csl Behring | $20.94 | 2019 | |
| Intra-Sana Laboratories | $15.98 | 2023 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Pharmacosmos Therapeutics INC. | $15.91 | 2025 | Monoferric |
| Shionogi INC | $15.42 | 2019 | |
| Exact Sciences Corporation | $14.73 | 2025 | Cologuard Collection Kit |
| Digestive Care, INC. | $3.62 | 2025 | Pertzye |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajan Khosla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.